Vytorin vs. Zetia

See how Vytorin and Zetia compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Vytorin is a fixed-dose combination of ezetimibe and simvastatin, while Zetia contains ezetimibe alone and is often paired with a separate statin.

  • Both drugs block cholesterol absorption in the gut, but Vytorin also lowers cholesterol production in the liver through its statin component.

  • Zetia is available as a low-cost generic, while Vytorin's added statin brings extra LDL-lowering power along with statin-related risks and a higher price.

Vytorin vs. Zetia Drug Summary

Vytorin

Vytorin combines ezetimibe and simvastatin, a cholesterol absorption inhibitor and a statin, in one tablet. It lowers LDL, total cholesterol, and triglycerides, and raises HDL cholesterol in adults with high cholesterol. It's taken as one tablet by mouth once daily.

Zetia

Zetia contains ezetimibe alone, a cholesterol absorption inhibitor that works in the gut rather than the liver. It's used to lower LDL cholesterol, either on its own or alongside a statin or fenofibrate. It's taken as one 10 mg tablet by mouth once daily.

Vytorin vs. Zetia Side Effects

Vytorin

Most common
headache (up to 5.8%)
increased ALT (up to 3.7%)
myalgia (up to 3.6%)
upper respiratory tract infection (up to 3.6%)

Zetia

Most common
upper respiratory tract infection (up to 4.3%)
diarrhea (up to 4.1%)
arthralgia (up to 3.0%)
sinusitis (up to 2.8%)

Vytorin vs. Zetia Dosage

Vytorin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg/10 mg once daily At the start
Maximum dose 10 mg/80 mg once daily If needed
Dose changes 3 increases As tolerated

Zetia

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily At the start
Maximum dose 10 mg once daily Same as starting
Dose changes None Fixed dose

Vytorin vs. Zetia Indications

Vytorin

Vytorin is FDA-approved to lower LDL cholesterol, total cholesterol, triglycerides, and Apo B, and to raise HDL cholesterol in adults with primary hyperlipidemia. It's also approved for homozygous familial hypercholesterolemia and homozygous sitosterolemia, rare inherited conditions that cause very high cholesterol levels.

  • Primary hyperlipidemia (high LDL, low HDL)

  • Homozygous familial hypercholesterolemia

  • Homozygous sitosterolemia

  • Elevated triglycerides

Zetia

Zetia is FDA-approved to lower LDL cholesterol in adults with primary hyperlipidemia, either alone or combined with a statin. It's also approved for mixed hyperlipidemia with fenofibrate, and for familial hypercholesterolemia, heterozygous in pediatric patients or homozygous in combination with a statin.

  • Primary hyperlipidemia, alone or with a statin

  • Mixed hyperlipidemia, with fenofibrate

  • Heterozygous familial hypercholesterolemia (age 10+, with statin)

  • Homozygous familial hypercholesterolemia (with statin)

Vytorin vs. Zetia Pros and Cons

Vytorin

Vytorin pairs a statin with a cholesterol absorption inhibitor in one pill, giving stronger LDL reduction than either drug alone. The IMPROVE-IT trial showed it lowered cardiovascular events compared with simvastatin alone in patients after a heart attack. It also carries statin-related risks, like myopathy and drug interactions, that ezetimibe alone does not.

Pros

  • Combines two cholesterol-lowering mechanisms in one pill

  • IMPROVE-IT trial showed reduced cardiovascular events post-heart attack

  • Approved for homozygous sitosterolemia, unlike ezetimibe alone

  • Fixed-dose tablet simplifies statin plus ezetimibe therapy

Cons

  • Contraindicated with strong CYP3A4 inhibitors due to myopathy risk

  • Carries statin-related muscle and liver risks

  • Not appropriate for active liver disease

  • Roughly $600 to $650 per month without insurance, before savings programs

Zetia

Zetia works only in the gut to block cholesterol absorption, so it avoids the muscle and liver risks tied to statins. It's often added to a statin for extra LDL lowering, but used alone it produces a smaller drop in LDL than combination therapy. It has been available as a generic since 2016, making it far less expensive than brand combination products.

Pros

  • Generic version available, roughly $8 to $50 per month

  • No statin-related muscle or liver risk when used alone

  • Flexible add-on to a statin or to fenofibrate

  • Single fixed 10 mg dose, no titration needed

Cons

  • Smaller LDL reduction than combination therapy

  • Not approved as monotherapy for homozygous familial hypercholesterolemia

  • Requires a separate statin pill for maximal LDL lowering

  • No cardiovascular outcomes trial for ezetimibe alone

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.